Fulton Financial Corporation

Fulton Financial Corp Reports Q1 2024 Financial Results, Reveals a Slight Dip Amid Robust Operational Performance

LANCASTER, PA — Fulton Financial Corporation (NASDAQ: FULT), recently announced its financial results for the first quarter of 2024, evident of a slight decrease but with stable operations. The corporation …

Fulton Financial Corp Reports Q1 2024 Financial Results, Reveals a Slight Dip Amid Robust Operational Performance Read More

Windtree Therapeutics

Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a leading biopharmaceutical company, delivered its financial results for the fourth quarter and fiscal year, that ended December 31, 2023.

Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023 Read More


Annovis Bio

Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials

MALVERN, PA — In a recent financial report for 2023, Annovis Bio, Inc. (NYSE: ANVS) proclaimed progress in the battle against neurodegenerative diseases; however, the path to potential breakthroughs has …

Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials Read More